“COMPARATIVE PHARMACOECONOMIC EVALUATION OF THE USE OF AFATINIB AND GEFITINIB IN THERAPY FOR LUNG CANCER”. Voprosy onkologii 63, no. 1 (January 1, 2017): 38–51. Accessed October 14, 2026. https://voprosyonkologii.ru/index.php/journal/article/view/671.